Soligenix (SNGX) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free SNGX Stock Alerts $0.40 -0.01 (-2.44%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSoligenix Announces Pricing of $4.75 Million Public Offeringprnewswire.com - April 18 at 8:30 AMSoligenix gains orphan drug status for MarVax vaccineinvesting.com - April 17 at 6:42 PMSage Therapeutics' Parkinson's drug fails in mid-stage studyfinance.yahoo.com - April 17 at 8:17 AMNanoscope Therapeutics to Present at the World Orphan Drug Congress 2024finance.yahoo.com - April 17 at 8:17 AMSNGX: Agreement with EMA on Second Confirmatory Trial for HyBryte™benzinga.com - April 16 at 8:46 PMSOLIGENIX, INC.: FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infectionfinanznachrichten.de - April 16 at 8:23 AMWhy Is Penny Stock Soligenix Trading Higher On Monday?finance.yahoo.com - April 15 at 6:01 PMSoligenix surges as MarVax vaccine secures Orphan Drug Designation from FDAproactiveinvestors.com - April 15 at 1:11 PMSoligenix Shares Rise After SuVax Gets Orphan Drug Designation from US FDAmarketwatch.com - April 15 at 1:00 PMSoligenix's MarVax Gets Orphan Drug Designationmarkets.businessinsider.com - April 15 at 1:00 PMSoligenix stock soars 106% on FDA orphan drug statusmsn.com - April 15 at 1:00 PMWhy Are Stocks Up Today?investorplace.com - April 15 at 12:06 PMWhy Is Soligenix (SNGX) Stock Up 58% Today?investorplace.com - April 15 at 11:18 AMmarketbeat.com - April 15 at 9:34 AMFDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infectionfinance.yahoo.com - April 15 at 7:59 AMSolinex Down On Orphan Drug Designationmsn.com - April 11 at 6:45 PMSNGX: Agreement with EMA on Second Confirmatory Trial for HyBryte™…finance.yahoo.com - April 11 at 6:45 PMSoligenix's SuVax Granted FDA Orphan Drug Designation For Prevention Of Sudan Ebolavirus Infectionmarkets.businessinsider.com - April 11 at 1:44 PMFDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infectionprnewswire.com - April 11 at 7:30 AMSoligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agencyprnewswire.com - April 3 at 7:30 AMSNGX: Discussions Continue with FDA Regarding Second Phase 3 Study for HyBryte™ in CTCL…finance.yahoo.com - March 20 at 3:55 PMSNGX Stock Earnings: Soligenix Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 15 at 3:02 PMRecap: Soligenix Q4 Earningsbenzinga.com - March 15 at 1:45 PMSoligenix Announces Recent Accomplishments and Year End 2023 Financial Resultsprnewswire.com - March 15 at 7:30 AMSoligenix Announces Formation of Behçet's Disease Medical Advisory Boardfinance.yahoo.com - February 8 at 7:40 AMSoligenix Inc.thestreet.com - February 1 at 12:56 PMSoligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TVfinanznachrichten.de - January 26 at 11:42 AMSoligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVfinance.yahoo.com - January 26 at 11:42 AMSoligenix to Present at The Microcap Conferencefinance.yahoo.com - January 25 at 9:03 AMSNGX: Phase 2a Psoriasis Trial Achieves Clinical Success…finance.yahoo.com - January 10 at 12:42 PMSoligenix Shares Rise 8% After SGX945 Gets FDA Fast Track Designationmarketwatch.com - January 8 at 1:03 PMFDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Diseasefinance.yahoo.com - January 8 at 8:02 AMSoligenix Reports Positive Preliminary Results From Phase 2a Study Of SGX302 In Psoriasismarkets.businessinsider.com - January 4 at 8:13 AMSoligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasisfinance.yahoo.com - January 4 at 8:13 AMSoligenix Shares Rise 19% After Vaccine Trial Shows Protection Against Two Virusesmarketwatch.com - January 2 at 12:56 PMSoligenix Reports Preclinical Efficacy Of Bivalent Vaccine Against Two Virusesmarkets.businessinsider.com - January 2 at 12:56 PMWhy Is Rare Disease Focused Soligenix Stock Soaring Today?msn.com - January 2 at 12:56 PMSoligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Virusesfinance.yahoo.com - January 2 at 12:56 PMHere's Why We Think Soligenix, Inc.'s (NASDAQ:SNGX) CEO Compensation Looks Fairfinance.yahoo.com - December 9 at 8:47 AM"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discoveryfinance.yahoo.com - December 1 at 9:34 AMWhy Is This Rare Disease-Focused Soligenix Stock Trading Over 200% Today?msn.com - November 30 at 1:49 PMmarketbeat.com - November 30 at 1:13 PMmarketbeat.com - November 30 at 12:47 PMmarketbeat.com - November 30 at 12:43 PMmarketbeat.com - November 30 at 12:32 PMWhy Is Soligenix (SNGX) Stock Up 285% Today?investorplace.com - November 30 at 12:00 PMmarketbeat.com - November 30 at 11:36 AMmarketbeat.com - November 30 at 11:10 AMmarketbeat.com - November 30 at 11:04 AMmarketbeat.com - November 30 at 10:52 AM Get Soligenix News Delivered to You Automatically Sign up to receive the latest news and ratings for SNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address How to camouflage a factory of 53,000 workers (Ad)"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio." Get the full story here. SNGX Media Mentions By Week SNGX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNGX News Sentiment▼-0.040.44▲Average Medical News Sentiment SNGX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNGX Articles This Week▼41▲SNGX Articles Average Week Get Soligenix News Delivered to You Automatically Sign up to receive the latest news and ratings for SNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PaxMedica News Today Bright Minds Biosciences News Today Synaptogenix News Today Petros Pharmaceuticals News Today LumiraDx News Today GT Biopharma News Today China Pharma News Today Sonnet BioTherapeutics News Today Kazia Therapeutics News Today Ensysce Biosciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNGX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsHow to camouflage a factory of 53,000 workersStansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soligenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
